The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data Sheila R. Reddy Eunice Chang Marian H. Tarbox Michael S. Broder Ryan S. Tieu Spencer Guthrie Montserrat V. Llonch Michael R. Pollock 10.6084/m9.figshare.12249746.v1 https://adisjournals.figshare.com/articles/figure/The_Clinical_and_Economic_Burden_of_Newly_Diagnosed_Hereditary_Transthyretin_ATTRv_Amyloidosis_A_Retrospective_Analysis_of_Claims_Data/12249746 <p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> 2020-05-18 16:03:08 Amyloidosis Cost Healthcare utilization Real-world